LIFEMD INC (LFMD)
US53216B1044 - Common Stock
Overall LFMD gets a fundamental rating of 3 out of 10. We evaluated LFMD against 40 industry peers in the Health Care Technology industry. Both the profitability and financial health of LFMD have multiple concerns. LFMD is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
LFMD had negative earnings in the past year.
LFMD had a positive operating cash flow in the past year.
In the past 5 years LFMD always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: LFMD reported negative operating cash flow in multiple years.
1.2 Ratios
LFMD's Return On Assets of -40.54% is in line compared to the rest of the industry. LFMD outperforms 43.59% of its industry peers.
LFMD's Return On Equity of -676.35% is on the low side compared to the rest of the industry. LFMD is outperformed by 82.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -40.54% | ||
| ROE | -676.35% | ||
| ROIC | N/A |
ROA(3y)-117.88%
ROA(5y)-183.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LFMD's Gross Margin of 87.61% is amongst the best of the industry. LFMD outperforms 94.87% of its industry peers.
In the last couple of years the Gross Margin of LFMD has grown nicely.
LFMD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.61% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.79%
GM growth 5Y2.59%
2. Health
2.1 Basic Checks
LFMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LFMD has been increased compared to 1 year ago.
Compared to 5 years ago, LFMD has more shares outstanding
The debt/assets ratio for LFMD is higher compared to a year ago.
2.2 Solvency
LFMD has an Altman-Z score of 2.09. This is not the best score and indicates that LFMD is in the grey zone with still only limited risk for bankruptcy at the moment.
LFMD's Altman-Z score of 2.09 is fine compared to the rest of the industry. LFMD outperforms 76.92% of its industry peers.
The Debt to FCF ratio of LFMD is 77.42, which is on the high side as it means it would take LFMD, 77.42 years of fcf income to pay off all of its debts.
LFMD has a better Debt to FCF ratio (77.42) than 64.10% of its industry peers.
A Debt/Equity ratio of 5.21 is on the high side and indicates that LFMD has dependencies on debt financing.
The Debt to Equity ratio of LFMD (5.21) is worse than 82.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.21 | ||
| Debt/FCF | 77.42 | ||
| Altman-Z | 2.09 |
ROIC/WACCN/A
WACC10.79%
2.3 Liquidity
LFMD has a Current Ratio of 1.22. This is a normal value and indicates that LFMD is financially healthy and should not expect problems in meeting its short term obligations.
LFMD's Current ratio of 1.22 is in line compared to the rest of the industry. LFMD outperforms 41.03% of its industry peers.
A Quick Ratio of 1.15 indicates that LFMD should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.15, LFMD is doing worse than 61.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 1.15 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 55.41% over the past year.
LFMD shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.16%.
The Revenue has been growing by 79.00% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)55.41%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q70%
Revenue 1Y (TTM)28.16%
Revenue growth 3Y59.92%
Revenue growth 5Y79%
Revenue growth Q2Q59.53%
3.2 Future
Based on estimates for the next years, LFMD will show a very strong growth in Earnings Per Share. The EPS will grow by 29.78% on average per year.
Based on estimates for the next years, LFMD will show a very strong growth in Revenue. The Revenue will grow by 28.64% on average per year.
EPS Next Y35.4%
EPS Next 2Y29.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year36.16%
Revenue Next 2Y28.64%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for LFMD. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LFMD. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
64.10% of the companies in the same industry are more expensive than LFMD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2032.11 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
LFMD's earnings are expected to grow with 29.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.78%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for LFMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
LIFEMD INC
NASDAQ:LFMD (4/29/2024, 7:11:15 PM)
After market: 11.58 -0.29 (-2.44%)11.87
-0.08 (-0.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap479.19M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -40.54% | ||
| ROE | -676.35% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.61% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.21 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.22 | ||
| Quick Ratio | 1.15 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)55.41%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y35.4%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)28.16%
Revenue growth 3Y59.92%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y